ROLE OF RHESUS ROTAVIRUS GENE 4 IN BILIARY ATRESIA

恒河猴轮状病毒基因 4 在胆道闭锁中的作用

基本信息

  • 批准号:
    8358153
  • 负责人:
  • 金额:
    $ 3.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Biliary atresia (BA) is a devastating disease of childhood. The etiology of BA remains uncertain; however, increasing evidence supports a viral component in disease pathogenesis. The murine model of BA is induced by perinatal infection with rhesus rotavirus (RRV) but not by other strains of rotavirus an example of which is TUCH. Rotavirus is a double-stranded RNA virus that contains 11 gene segments. To determine which RRV gene segment is responsible for disease pathogenesis, we used the parental strains RRV and TUCH and the rotavirus property of reassortment to generate a complete set of single gene reassortants. Eleven single-gene "loss-of-function" reassortants in which a TUCH gene replaced its RRV equivalent and eleven reciprocal single gene "gain-of-function" reassortants in which a RRV gene replaced its TUCH equivalent were generated. Infection of mice with the "loss-of-function" reassortant RT4 where gene segment 4 from TUCH was placed on an RRV background eliminated RRV's ability to cause murine BA. In a reciprocal fashion, the "gain-of-function" reassortant TR4 resulted in murine BA with a mortality rate of 95%. Cholangiocyte binding and infectivity assays revealed RT4 binding ratio and titer (both in vivo and in vitro) were significantly attenuated as compared with RRV; moreover, TR4 binding and titer were significantly higher than TUCH. Reassortant RT3 and TR3 induced an intermediate phenotype. Gene segment 4 through its translated gene product VP4 plays a significant role governing RRV tropism for the biliary epithelial cell and induces the murine model of biliary atresia. The basis for tropism and how it induces biliary obstruction requires further study. Substitution of RRV gene segment 3 did not affect viral infectivity in vitro, but altered the in vivo effect.
这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的, 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量, 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 胆道闭锁(BA)是一种毁灭性的儿童疾病。BA的病因仍然不确定,然而,越来越多的证据支持疾病发病机制中的病毒成分。BA的鼠模型是由恒河猴轮状病毒(RRV)的围产期感染诱导的,而不是由其他轮状病毒株(TUCH)诱导的。轮状病毒是一种双链RNA病毒,含有11个基因片段。为了确定哪一个RRV基因片段负责疾病的发病机制,我们使用亲本株RRV和TUCH以及轮状病毒的重配特性来产生一套完整的单基因重组体。产生了11个TUCH基因取代其RRV等价物的单基因“功能丧失”的resistant和11个RRV基因取代其TUCH等价物的相互单基因“功能获得”的resistant。用“功能丧失”的重组体RT 4感染小鼠,其中来自TUCH的基因片段4被置于RRV背景上,消除了RRV引起小鼠BA的能力。以相反的方式,“功能获得性”抑制剂TR 4导致小鼠BA,死亡率为95%。胆管细胞结合和感染性测定显示,RT 4结合率和滴度(体内和体外)与RRV相比显著减弱;此外,TR 4结合率和滴度显著高于TUCH。抗性株RT 3和TR 3诱导中间型。 基因片段4通过其翻译的基因产物VP 4在控制RRV对胆管上皮细胞的嗜性并诱导胆道闭锁的小鼠模型中起重要作用。 归经的基础及其如何诱发胆道梗阻尚需进一步研究。RRV基因片段3的替换不影响病毒的体外感染性,但改变了体内效应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAROL SESTAK其他文献

KAROL SESTAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAROL SESTAK', 18)}}的其他基金

DEVELOPMENT OF Q PCR ASSAY FOR DETECTION OF ENTERIC CALICIVIRUSES
用于检测肠道杯状病毒的 Q PCR 检测方法的开发
  • 批准号:
    8358112
  • 财政年份:
    2011
  • 资助金额:
    $ 3.72万
  • 项目类别:
GENETIC DIVERSITY AMONG RHESUS ENTERIC CALICIVIRUSES
恒河猴肠杯状病毒的遗传多样性
  • 批准号:
    8358072
  • 财政年份:
    2011
  • 资助金额:
    $ 3.72万
  • 项目类别:
ROTAVIRUSES HAVE DIVERGENT GENE CONSTELLATIONS
轮状病毒具有不同的基因群
  • 批准号:
    8358125
  • 财政年份:
    2011
  • 资助金额:
    $ 3.72万
  • 项目类别:
XENOBIOTIC METABOLISM AND CANCER IN GLUTEN-SENSITIVE MACAQUES
麸质敏感猕猴的异生代谢与癌症
  • 批准号:
    8358154
  • 财政年份:
    2011
  • 资助金额:
    $ 3.72万
  • 项目类别:
CHARACTERIZATION OF GLUTEN-SENSISTIVE RHESUS MACAQUES
麸质敏感恒河猴的特征
  • 批准号:
    8358073
  • 财政年份:
    2011
  • 资助金额:
    $ 3.72万
  • 项目类别:
NORO-, SAPO- & RHESUS ENTERIC CALICIVIRUS-SPECIFIC ANTIBODIES IN MACAQUES
NORO-、SAPO-
  • 批准号:
    8358093
  • 财政年份:
    2011
  • 资助金额:
    $ 3.72万
  • 项目类别:
DEVELOPMENT OF RT PCR ASSAY FOR QUANTITATIVE DETECTION OF ENTERIC CALICIVIRUSES
肠道杯状病毒定量检测 RT PCR 检测方法的开发
  • 批准号:
    8173022
  • 财政年份:
    2010
  • 资助金额:
    $ 3.72万
  • 项目类别:
GENETIC DIVERSITY AMONG RHESUS ENTERIC CALICIVIRUSES
恒河猴肠杯状病毒的遗传多样性
  • 批准号:
    8172967
  • 财政年份:
    2010
  • 资助金额:
    $ 3.72万
  • 项目类别:
NONINFLAMMATORY GLUTEN PEPTIDE ANALOGUES AS BIOMARKERS FOR CELIAC SPRUE
非炎症性麸质肽类似物作为乳糜泻的生物标志物
  • 批准号:
    8172996
  • 财政年份:
    2010
  • 资助金额:
    $ 3.72万
  • 项目类别:
NORO-, SAPO- & RHESUS ENTERIC CALICIVIRUS-SPECIFIC ANTIBODIES IN YOUNG MACAQUES
NORO-、SAPO-
  • 批准号:
    8172995
  • 财政年份:
    2010
  • 资助金额:
    $ 3.72万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 3.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 3.72万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 3.72万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 3.72万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 3.72万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 3.72万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 3.72万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 3.72万
  • 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 3.72万
  • 项目类别:
    Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 3.72万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了